Updated 04:19 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,872.70 -0.35% CL 84.95 -4.08% BTC 64,888.19 -0.64%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,873 −0.35% BTC $64,888 −0.64% VIX 22.91 +18.70% latest tape · as of 04:19 UTC
The Screen · Technology · Computer Hardware

AstroNova, Inc.

ALOT · Nasdaq · USD · Market cap $131M · 398 employees

AstroNova, Inc.

FAIL · Does not pass the screen
28.99 USD

Price as of 28 Aug 2026Daily close, not a live quoteLast reviewed 81 days ago

Screened 2026-08-28 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price28.99 USD at the 28 Aug 2026 close
  • Fair valueUnder review: its inputs are 79 days old; there is no analyst estimate to cross-check it.
  • Our regime readAccumulation, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed28 Aug 2026 (81 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-08-28).

Current read
Accumulation ?
Screened · screened 2026-08-28
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price28.99 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-07-02Read Accumulation16.97+70.8% to today ✓First review on file: Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

AstroNova, Inc. holds its Accumulation at $28.99. Elevated stress, defensive posture warranted, held for 12 days.

As held on the ledger · 2026-08-28
PhaseAccumulation
Quantitative stateElevated stress, defensive posture warranted, held for 12 days
Price at the screen$28.99
ValuationN/A trailing · 82.83 forward price to earnings
Values screenFAIL · score 70.0
Beta1.00
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 34.15% Below 33% Interest-bearing debt is 34.1% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 3.46% Below 33% Cash held in interest-bearing accounts and securities is 3.5% of assets, under the one-third limit. Pass
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

AstroNova,'s business is in a permissible area, but its interest-bearing debt is about 34% of the company, just over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when ALOT's ethical verdict changes

Today ALOT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Its inputs are 79 days old; there is no analyst estimate to cross-check it. We show no fair value, margin of safety or value read built on it until the review clears.

How a fair value is estimated: discounted cash flow (DCF).

Price History & Projections

Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-08-28 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E82.8xexpensive even after accounting for its growth
EPS, trailing-0.18
EPS, forward0.35
Revenue growth+4.4%slow but positive growth
Profit margin-0.9%currently unprofitable
Return on equity-1.8%not currently earning a positive return on equity
Debt to equity0.49minimal debt: a conservative balance sheet
Beta1.00moves a little more than the market
52-week range6.96 - 17.49
MoatWEAK
Market cap$131M
Employees398

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

ALOT trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-07 Accumulation $28.99 +0.0% Entry 11

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 119% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-10-27 Accumulation $28.99 +0.0% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 119% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-10-12 Accumulation $28.99 +0.0% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-10-02 Accumulation $28.99 +70.8% Entry 8

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 70.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-09-21 Accumulation $16.97 +0.0% Entry 7

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-08-21 Accumulation $16.97 +0.0% Entry 6

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-07-21 Accumulation $16.97 +0.0% Entry 5

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-07-18 Accumulation $16.97 +0.0% Entry 4

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-07-17 Accumulation $16.97 +0.0% Entry 3

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 75%. Our forward projection puts the odds of a 10% gain over the next month near 23%.

2026-07-03 Accumulation $16.97 +0.0% Entry 2

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $14.57 +8.0% · $1,080 +8.0%
2 months $11.57 +36.0% · $1,360 +36.0%
3 months $8.78 +79.3% · $1,793 +79.3%
6 months $7.45 +111.3% · $2,113 +111.3%
1 year $9.01 +74.7% · $1,747 +74.7%
2 years $17.08 -7.9% · $922 -7.9%
3 years $15.35 +2.5% · $1,025 +2.5%
5 years $14.75 +6.7% · $1,067 +6.7%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever ALOT does next, these words stay.

AstroNova, Inc. · ALOT · Accumulation · $28.99
Recorded 2026-08-28 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.